The national genomic test directory specifies which genomic tests are commissioned by the NHS in England and the patients who are eligible to access to each test. The directory is regularly updated and clinicians should check the current version of the directory before referring patients.
Access the current edition of the directory (opens in a new tab) (opens in a new tab). Please review this information and the NHSE published documents to ensure you are aware of any updates that may affect your practice.
Updates to the directory are made once they are approved by the NHS and are summarised below. From the time of the update, it can take up to three months for significant changes and new tests to become fully available. This is due to the time it can take to develop, implement and verify new testing procedures.
February 2024
The following new clinical indications available for testing were added in February 2024:
| Clinical Indication Test Code | Clinical Indication |
|---|---|
| Clinical Indication Test Code R445 | Clinical Indication Common aneuploidy testing - NIPT |
The pathway for this testing is due to be implemented within maternity services across the East Genomics region by 1st April 2024.
Samples and test orders should be routed to the NIPT laboratory currently delivering testing for the Fetal Anomaly Screening Program.
DO NOT SEND SAMPLES TO YOUR LOCAL GENOMICS LABORATORY HUB.